Radiotherapy for bladder cancer

被引:59
作者
Milosevic, Michael
Gospodarowicz, Mary
Zietman, Anthony
Abbas, Farhat
Haustermans, Karin
Moonen, Luc
Rodel, Claus
Schoenberg, Mark
Shipley, William
机构
[1] Princess Margaret Hosp, Radiat Med Program, Toronto, ON M5G 2M9, Canada
[2] Univ Toronto, Dept Radiat Oncol, Toronto, ON, Canada
[3] Massachusetts Gen Hosp, Dept Radiat Oncol, Boston, MA 02114 USA
[4] Aga Khan Univ Hosp, Dept Urol, Karachi, Pakistan
[5] Univ Hosp Gasthuisberg, Dept Radiat Oncol, B-3000 Louvain, Belgium
[6] Netherlands Canc Inst, Dept Radiotherapy, Amsterdam, Netherlands
[7] Univ Erlangen Nurnberg, Dept Radiat Therapy, Erlangen, Germany
[8] Johns Hopkins Med Inst, Dept Urol, Baltimore, MD 21205 USA
关键词
D O I
10.1016/j.urology.2006.05.060
中图分类号
R5 [内科学]; R69 [泌尿科学(泌尿生殖系疾病)];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
The radiotherapy panel met to develop international consensus about the optimal use of radiotherapy, alone or in combination with surgery and chemotherapy, in the radical treatment of patients with bladder cancer. A consensus meeting of experts in the treatment of bladder cancer was convened by the Societe Internationale d'Urologie (SIU). The radiotherapy committee, which had international representation from 6 countries, performed a critical review of the English-language literature and developed evidence-based guidelines for the use of radiotherapy in the treatment of patients with bladder cancer. The strength of the evidence supporting each recommendation was ranked according to a 4-point scale. Consensus statements were developed that address (1) the effectiveness of radiotherapy in the treatment of bladder cancer, (2) the most appropriate patients for curative treatment with radiotherapy, (3) the optimal method of delivery of radiotherapy, (4) the best radiation prescription for treating bladder cancer, and (5) optimal management of the patient's condition after radiotherapy has been provided. Radiotherapy is effective treatment for selected patients with bladder cancer; it produces long-term disease control with preservation of normal bladder function. Modern radiotherapy treatment techniques offer the potential to improve cure rates and reduce adverse effects. All patients in whom the condition is newly diagnosed should be assessed in a multidisciplinary setting, where the relative merits of surgery, radiotherapy, and chemotherapy can be considered on an individual basis with the aim of optimizing overall outcomes.
引用
收藏
页码:80 / 92
页数:13
相关论文
共 111 条
[1]
Abol-Enein H, 2003, LANCET, V361, P1927
[2]
ABRAMS P, INCONTINENCE, V1, P10
[3]
SALVAGE CYSTECTOMY AFTER RADICAL IRRADIATION FOR BLADDER-CANCER - PROGNOSTIC FACTORS AND COMPLICATIONS [J].
ABRATT, RP ;
WILSON, JA ;
PONTIN, AR ;
BARNES, RD .
BRITISH JOURNAL OF UROLOGY, 1993, 72 (05) :756-760
[4]
Agranovich Alexander, 2003, Can J Urol, V10, P2056
[5]
ANDERSTROM C, 1983, EUR UROL, V9, P142
[6]
[Anonymous], 1987, FRACTIONATION RADIOT
[7]
What is new in bladder cancer imaging [J].
Barentsz, JO ;
Witjes, JA ;
Ruijs, JHJ .
UROLOGIC CLINICS OF NORTH AMERICA, 1997, 24 (03) :583-&
[8]
Prognostic factors of outcome after radical cystectomy for bladder cancer: A retrospective study of a homogeneous patient cohort [J].
Bassi, P ;
Ferrante, GD ;
Piazza, N ;
Spinadin, R ;
Carando, R ;
Pappagallo, G ;
Pagano, F .
JOURNAL OF UROLOGY, 1999, 161 (05) :1494-1497
[9]
Blandy J P, 1988, Prog Clin Biol Res, V260, P447
[10]
T3 BLADDER-CANCER - THE CASE FOR SALVAGE CYSTECTOMY [J].
BLANDY, JP ;
ENGLAND, HR ;
EVANS, SJW ;
HOPESTONE, HF ;
MAIR, GMM ;
MANTELL, BS ;
OLIVER, RTD ;
PARIS, AMI ;
RISDON, RA .
BRITISH JOURNAL OF UROLOGY, 1980, 52 (06) :506-510